MSI Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

MSI Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$48K	Buy	1,756 +672	+62%	+$27K	﹤0.01%	1895
2016 Q3	$66K	Sell	1,084 -1,035	-49%	-$31.3K	﹤0.01%	1664
2016 Q2	$41K	Buy	2,119 +1,253	+145%	+$23.2K	﹤0.01%	1922
2016 Q1	$17K	Sell	866 -150	-15%	-$2.62K	﹤0.01%	2416
2015 Q4	$39K	Buy	1,016 +266	+35%	+$8.63K	﹤0.01%	1886
2015 Q3	$24K	Hold	750	–	–	﹤0.01%	1622
2015 Q2	$23K	Buy	750 +161	+27%	+$3.29K	﹤0.01%	1730
2015 Q1	$8K	Hold	589	–	–	﹤0.01%	2254
2014 Q4	$9K	Hold	589	–	–	﹤0.01%	1890
2014 Q3	$12K	Hold	589	–	–	﹤0.01%	1744
2014 Q2	$18K	Sell	589 -75	-11%	-$2.37K	﹤0.01%	1549
2014 Q1	$16K	Buy	664 +164	+33%	+$4.18K	﹤0.01%	1534
2013 Q4	$10K	Buy	+500	New	+$14.9K	﹤0.01%	1701

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSI Financial Services's SRPT Position: Q4 2016 in Review

MSI Financial Services increased its Sarepta Therapeutics (SRPT) stake by 62% in Q4 2016, buying an estimated $27K and bringing the position to 1,756 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

MSI Financial Services first reported a position in SRPT in Q4 2013 and has held it in 13 quarters since. The position peaked at $66K in Q3 2016. 178 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

MSI Financial Services held 1,756 shares of Sarepta Therapeutics worth $48K as of Q4 2016.
MSI Financial Services bought 672 Sarepta Therapeutics shares in Q4 2016, an estimated $27K.
Sarepta Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1895 holding.
MSI Financial Services first reported a position in Sarepta Therapeutics in Q4 2013 and has held it in 13 quarters since.
MSI Financial Services's Sarepta Therapeutics position peaked at $66K in Q3 2016.
178 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.